Daridorexant
Published , updated
Unassigned
New Medicines
Insomnia in adults
Information
New molecular entity
Idorsia
Idorsia
Development and Regulatory status
None
Phase III Clinical Trials
Phase III Clinical Trials
Category
A dual orexin receptor antagonist
The Great British Sleep Survey (2011) identified that 45.7% of adults have insomnia disorder (28,092,168 people) [1].
Insomnia in adults
Oral